Paul D Greig
Overview
Explore the profile of Paul D Greig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
2646
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yohanathan L, Loveday B, Brar N, Greig P, McGilvray I, Moulton C, et al.
HPB (Oxford)
. 2020 Feb;
22(11):1563-1568.
PMID: 32081539
Background: Spleen preservation during distal pancreatectomy (SpDP) can be accomplished by a variety of surgical approaches, but the impact on spleen function is unknown. This study aimed to compare spleen...
2.
Yohanathan L, Dossa F, St Germain A, Golbafian F, Moulton C, McGilvray I, et al.
Pancreatology
. 2019 Feb;
19(2):360-366.
PMID: 30803874
Background: /Objective. To determine the outcomes of a non-operative management approach for sporadic, small, non-functional pancreatic neuroendocrine tumours. Methods: A retrospective chart review of patients with non-functional pancreatic neuroendocrine tumours...
3.
Gorgen A, Rosales R, Sadler E, Beecroft R, Knox J, Dawson L, et al.
Transplantation
. 2019 Feb;
103(10):2136-2143.
PMID: 30801510
Background: There is a lack of information about survival after dropout from the liver transplant waiting list. Therefore, we aimed to assess the overall survival, and risk factors for death,...
4.
Loveday B, Jaberi A, Moulton C, Wei A, Gallinger S, Beecroft R, et al.
HPB (Oxford)
. 2019 Feb;
21(8):1072-1078.
PMID: 30797726
Background: Portal vein embolization (PVE) is used before major hepatectomy for hepatocellular carcinoma (HCC) to increase future liver remnant (FLR) volume. However, this may increase tumour growth rate, leading to...
5.
Goldaracena N, Gorgen A, Doyle A, Hansen B, Tomiyama K, Zhang W, et al.
J Hepatol
. 2019 Jan;
70(4):666-673.
PMID: 30630009
Background & Aims: There are conflicting reports on the outcomes after live donor liver transplantation in patients with hepatocellular carcinoma (HCC). We aimed to compare the survival of patients with...
6.
Doyle A, Gorgen A, Muaddi H, Aravinthan A, Issachar A, Mironov O, et al.
J Hepatol
. 2019 Jan;
70(5):866-873.
PMID: 30615906
Background & Aims: Radiofrequency ablation (RFA) is an effective treatment for single hepatocellular carcinoma (HCC) ≤3 cm. Disease recurrence is common, and in some patients will occur outside transplant criteria....
7.
Loveday B, Dib M, Sequeira S, Alotaiby N, Visser R, Barbas A, et al.
HPB (Oxford)
. 2018 Oct;
21(1):114-120.
PMID: 30322713
Background: The left renal vein (LRV) may be used for venous reconstruction during hepato-pancreato-biliary (HPB) surgery, although concerns exist about compromising renal function. This study aimed to determine renal outcomes...
8.
Kollmann D, Goldaracena N, Sapisochin G, Linares I, Selzner N, Hansen B, et al.
Liver Transpl
. 2018 Sep;
24(11):1512-1522.
PMID: 30264930
The outcome after living donor liver transplantation (LDLT) using grafts with multiple bile ducts (BDs) remains unclear. We analyzed 510 patients who received an adult-to-adult right lobe LDLT between 2000...
9.
Goldaracena N, Barbas A, Galante A, Sapisochin G, Al-Adra D, Selzner N, et al.
Clin Transplant
. 2018 Jun;
32(8):e13304.
PMID: 29947154
Using our prospectively collected database all adult hepatitis C virus (HCV)-positive patients receiving an adult-to-adult LDLT between October 2000 and May 2014 were identified. Outcome of LDLT with grafts from...
10.
Barbas A, Levy J, Mulvihill M, Goldaracena N, Dib M, Al-Adra D, et al.
Transplant Direct
. 2018 May;
4(5):e348.
PMID: 29796419
Background: The use of venovenous bypass in liver transplantation has declined over time. Few studies have examined the impact of surgical approach in cases performed exclusively without venovenous bypass. We...